Bombus pyrosoma isolate SC7728 linkage group LG17, ASM1482585v1, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Hymenoptera; Apocrita; Aculeata; Apoidea; Apidae; Bombus; Melanobombus.
Genus-wide characterization of bumblebee genomes provides insights into their evolution and variation in ecological and behavioral traits
Publication Status: Available-Online prior to print
REFSEQ INFORMATION: The reference sequence is identical to\nCM026141.1.\nAssembly name: ASM1482585v1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Chinese Academy of\nAgricultural Sciences on 2020/10/02. The original whole-genome\nshotgun project has the accession JACXIN000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Chinese Academy of Agricultural Sciences\nAssembly Date :: DEC-2017\nAssembly Method :: DISCOVAR de novo v. 52488\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 100x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Bombus pyrosoma Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4-like, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4-like, transcript variant X2
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4-like isoform X1
alpha-ketoglutarate-dependent dioxygenase alkB homolog 4-like isoform X2
CD63 antigen-like, transcript variant X1
CD63 antigen-like, transcript variant X4
CD63 antigen-like, transcript variant X5
CD63 antigen-like, transcript variant X7
CD63 antigen-like, transcript variant X3
CD63 antigen-like, transcript variant X2
CD63 antigen-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA serine (anticodon UGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ubiquitin-conjugating enzyme E2-24 kDa, transcript variant X2
ubiquitin-conjugating enzyme E2-24 kDa, transcript variant X1
microspherule protein 1, transcript variant X4
microspherule protein 1, transcript variant X5
microspherule protein 1, transcript variant X6
peptidoglycan-recognition protein 2-like
microspherule protein 1, transcript variant X12
microspherule protein 1, transcript variant X3
microspherule protein 1, transcript variant X8
microspherule protein 1, transcript variant X11
microspherule protein 1, transcript variant X2
microspherule protein 1, transcript variant X10
microspherule protein 1, transcript variant X7
microspherule protein 1, transcript variant X1
microspherule protein 1, transcript variant X9
abscisic acid and environmental stress-inducible protein-like
serine/threonine-protein phosphatase 4 catalytic subunit
low-density lipoprotein receptor-related protein 6
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6, transcript variant X2
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6, transcript variant X1
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 isoform X1
NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 isoform X2
rab5 GDP/GTP exchange factor, transcript variant X1
rab5 GDP/GTP exchange factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 1, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X1
ubiquinol-cytochrome-c reductase complex assembly factor 1 isoform X2
uncharacterized LOC122576839, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122576839, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122576839, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122576839, transcript variant X2
uncharacterized LOC122576839, transcript variant X3
uncharacterized protein LOC122576839 isoform X1
uncharacterized LOC122576839, transcript variant X6
uncharacterized protein LOC122576839 isoform X2
uncharacterized LOC122576841, transcript variant X2
uncharacterized LOC122576841, transcript variant X1
uncharacterized LOC122576841, transcript variant X3
mediator of RNA polymerase II transcription subunit 14
tubulin-specific chaperone D, transcript variant X3
zinc finger protein 800, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 800, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 800, transcript variant X5
zinc finger protein 800, transcript variant X1
zinc finger protein 800, transcript variant X2
uncharacterized protein LOC122577039 isoform X3
tubulin-specific chaperone D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubulin-specific chaperone D, transcript variant X1
alpha-(1,3)-fucosyltransferase 10, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 10, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 10, transcript variant X2
alpha-(1,3)-fucosyltransferase 10, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
alpha-(1,3)-fucosyltransferase 10 isoform X4
alpha-(1,3)-fucosyltransferase 10 isoform X2
alpha-(1,3)-fucosyltransferase 10 isoform X3
alpha-(1,3)-fucosyltransferase 10 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122576895, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122576895, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC122576895, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COMM domain-containing protein 3-like, transcript variant X7
COMM domain-containing protein 3-like, transcript variant X9
COMM domain-containing protein 3-like, transcript variant X3
COMM domain-containing protein 3-like, transcript variant X1
COMM domain-containing protein 3-like isoform X1
COMM domain-containing protein 3-like isoform X3
COMM domain-containing protein 3-like, transcript variant X8
COMM domain-containing protein 3-like, transcript variant X6
COMM domain-containing protein 3-like, transcript variant X2
COMM domain-containing protein 3-like, transcript variant X4
COMM domain-containing protein 3-like, transcript variant X5
COMM domain-containing protein 3-like isoform X2
serine-rich adhesin for platelets-like isoform X2
uncharacterized LOC122576974, transcript variant X1
uncharacterized LOC122576974, transcript variant X3
uncharacterized LOC122576974, transcript variant X2
uncharacterized protein LOC122576974 isoform X1
uncharacterized protein LOC122576974 isoform X2
uncharacterized LOC122576972, transcript variant X2
uncharacterized protein LOC122576972 isoform X2
uncharacterized LOC122576972, transcript variant X3
uncharacterized LOC122576972, transcript variant X1
uncharacterized protein LOC122576972 isoform X1
uncharacterized protein LOC122576972 isoform X3
H(+)/Cl(-) exchange transporter 5, transcript variant X4
H(+)/Cl(-) exchange transporter 5, transcript variant X3
H(+)/Cl(-) exchange transporter 5, transcript variant X2
H(+)/Cl(-) exchange transporter 5, transcript variant X1
H(+)/Cl(-) exchange transporter 5, transcript variant X5
H(+)/Cl(-) exchange transporter 5, transcript variant X6
H(+)/Cl(-) exchange transporter 5 isoform X1
H(+)/Cl(-) exchange transporter 5 isoform X2
H(+)/Cl(-) exchange transporter 5 isoform X3
sodium channel protein 60E-like, transcript variant X1
sodium channel protein 60E-like, transcript variant X2
sodium channel protein 60E-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sodium channel protein 60E-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sodium channel protein 60E-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sodium channel protein 60E-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
sodium channel protein 60E-like isoform X1
sodium channel protein 60E-like isoform X2
sodium channel protein 60E-like isoform X3
sodium channel protein 60E-like isoform X4
sodium channel protein 60E-like isoform X5
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X4
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial, transcript variant X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X3
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X2
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X1
NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial isoform X4
exosome complex component MTR3-like, transcript variant X2
exosome complex component MTR3-like, transcript variant X1
exosome complex component MTR3-like isoform X1
exosome complex component MTR3-like, transcript variant X3
exosome complex component MTR3-like isoform X2
TATA-box-binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
TATA-box-binding protein, transcript variant X1
asparagine--tRNA ligase, cytoplasmic, transcript variant X1
asparagine--tRNA ligase, cytoplasmic, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
cilia- and flagella-associated protein 44, transcript variant X1
cilia- and flagella-associated protein 44, transcript variant X2
cilia- and flagella-associated protein 44 isoform X1
cilia- and flagella-associated protein 44 isoform X2
cilia- and flagella-associated protein 44, transcript variant X3
cilia- and flagella-associated protein 44 isoform X3
AP-2 complex subunit sigma, transcript variant X3
AP-2 complex subunit sigma, transcript variant X4
AP-2 complex subunit sigma, transcript variant X5
AP-2 complex subunit sigma, transcript variant X2
AP-2 complex subunit sigma, transcript variant X1
heparin sulfate O-sulfotransferase, transcript variant X2
heparin sulfate O-sulfotransferase, transcript variant X3
heparin sulfate O-sulfotransferase isoform X2
heparin sulfate O-sulfotransferase isoform X3
heparin sulfate O-sulfotransferase, transcript variant X1
heparin sulfate O-sulfotransferase isoform X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X3
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X1
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X2
N-terminal Xaa-Pro-Lys N-methyltransferase 1, transcript variant X4
N-terminal Xaa-Pro-Lys N-methyltransferase 1
zinc finger protein 568-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
zinc finger protein 568-like, transcript variant X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X2
putative ATP-dependent RNA helicase TDRD12, transcript variant X3
putative ATP-dependent RNA helicase TDRD12, transcript variant X1
putative ATP-dependent RNA helicase TDRD12 isoform X2
putative ATP-dependent RNA helicase TDRD12 isoform X3
putative ATP-dependent RNA helicase TDRD12 isoform X1
uncharacterized LOC122577113, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122577113, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122577113, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122577113, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122577113 isoform X1
uncharacterized protein LOC122577113 isoform X2
39S ribosomal protein L42, mitochondrial, transcript variant X2
39S ribosomal protein L42, mitochondrial, transcript variant X1
39S ribosomal protein L42, mitochondrial
coiled-coil domain-containing protein 40, transcript variant X1
coiled-coil domain-containing protein 40, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coiled-coil domain-containing protein 40 isoform X1
coiled-coil domain-containing protein 40 isoform X2
facilitated trehalose transporter Tret1-like
uncharacterized LOC122577120, transcript variant X3
uncharacterized LOC122577120, transcript variant X2
uncharacterized LOC122577120, transcript variant X1
uncharacterized LOC122577120, transcript variant X10
uncharacterized LOC122577120, transcript variant X8
uncharacterized LOC122577120, transcript variant X7
uncharacterized LOC122577120, transcript variant X5
uncharacterized LOC122577120, transcript variant X6
uncharacterized LOC122577120, transcript variant X9
uncharacterized LOC122577120, transcript variant X4
uncharacterized protein LOC122577120 isoform X1
uncharacterized protein LOC122577120 isoform X2
DNA replication licensing factor MCM4, transcript variant X2
DNA replication licensing factor MCM4, transcript variant X3
DNA replication licensing factor MCM4, transcript variant X1
exocyst complex component 7, transcript variant X2
exocyst complex component 7, transcript variant X1
phosphoribosyl pyrophosphate synthase-associated protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
rho GDP-dissociation inhibitor 2, transcript variant X1
rho GDP-dissociation inhibitor 2, transcript variant X3
rho GDP-dissociation inhibitor 2, transcript variant X2
rho GDP-dissociation inhibitor 1 isoform X1
rho GDP-dissociation inhibitor 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin-conjugating enzyme E2 T-like, transcript variant X3
ubiquitin-conjugating enzyme E2 T-like, transcript variant X1
ubiquitin-conjugating enzyme E2 T-like, transcript variant X5
ubiquitin-conjugating enzyme E2 T-like, transcript variant X2
ubiquitin-conjugating enzyme E2 T-like, transcript variant X4
ubiquitin-conjugating enzyme E2 T-like isoform X1
ubiquitin-conjugating enzyme E2 T-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
single-stranded DNA-binding protein, mitochondrial
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X11
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X13
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-like isoform X2
gamma-aminobutyric acid receptor subunit beta-like isoform X1
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X12
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X14
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X4
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X5
gamma-aminobutyric acid receptor subunit beta-like isoform X4
gamma-aminobutyric acid receptor alpha-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC122577143, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122577143, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X3
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X7
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X10
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X9
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X6
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X8
gamma-aminobutyric acid receptor subunit beta-like isoform X3
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X15
gamma-aminobutyric acid receptor subunit beta-like, transcript variant X16
gamma-aminobutyric acid receptor subunit beta-like isoform X5
tumor necrosis factor receptor superfamily member wengen, transcript variant X3
tumor necrosis factor receptor superfamily member wengen, transcript variant X2
tumor necrosis factor receptor superfamily member wengen, transcript variant X1
tumor necrosis factor receptor superfamily member wengen isoform X1
tumor necrosis factor receptor superfamily member wengen, transcript variant X4
tumor necrosis factor receptor superfamily member wengen isoform X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9
FAD-dependent oxidoreductase domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FAD-dependent oxidoreductase domain-containing protein 1 isoform X1
FAD-dependent oxidoreductase domain-containing protein 1, transcript variant X2
FAD-dependent oxidoreductase domain-containing protein 1 isoform X2
rab proteins geranylgeranyltransferase component A 1
zinc finger protein ztf-16, transcript variant X3
zinc finger protein ztf-16, transcript variant X1
zinc finger protein ztf-16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122577034, transcript variant X1
uncharacterized LOC122577034, transcript variant X2
uncharacterized protein LOC122577034 isoform X1
uncharacterized protein LOC122577034 isoform X2
endoribonuclease Dcr-1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
endoribonuclease Dcr-1, transcript variant X1
GATOR complex protein NPRL3, transcript variant X2
GATOR complex protein NPRL3, transcript variant X1
GATOR complex protein NPRL3, transcript variant X3
uncharacterized LOC122577031, transcript variant X1
uncharacterized LOC122577031, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized protein LOC122577031 isoform X1
uncharacterized protein LOC122577031 isoform X2
sentrin-specific protease 1-like, transcript variant X1
sentrin-specific protease 1-like, transcript variant X2
threonine aspartase 1-like, transcript variant X1
threonine aspartase 1-like, transcript variant X2
RNA-binding motif protein, X-linked 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
katanin p60 ATPase-containing subunit A-like 1, transcript variant X1
katanin p60 ATPase-containing subunit A-like 1, transcript variant X2
katanin p60 ATPase-containing subunit A-like 1, transcript variant X7
katanin p60 ATPase-containing subunit A-like 1, transcript variant X4
katanin p60 ATPase-containing subunit A-like 1, transcript variant X5
katanin p60 ATPase-containing subunit A-like 1, transcript variant X6
katanin p60 ATPase-containing subunit A-like 1, transcript variant X3
katanin p60 ATPase-containing subunit A-like 1 isoform X1
katanin p60 ATPase-containing subunit A-like 1 isoform X2
katanin p60 ATPase-containing subunit A-like 1 isoform X5
katanin p60 ATPase-containing subunit A-like 1 isoform X3
katanin p60 ATPase-containing subunit A-like 1 isoform X4
katanin p60 ATPase-containing subunit A-like 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
UDP-xylose and UDP-N-acetylglucosamine transporter
X-ray repair cross-complementing protein 5-like, transcript variant X3
X-ray repair cross-complementing protein 5-like, transcript variant X1
X-ray repair cross-complementing protein 5-like, transcript variant X2
X-ray repair cross-complementing protein 5-like
cytochrome P450 4c3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 4c3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome P450 4c3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cytochrome P450 4c3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 49 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cytochrome P450 4c3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122577032, transcript variant X2
uncharacterized LOC122577032, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122576990, transcript variant X2
uncharacterized LOC122576990, transcript variant X1
uncharacterized LOC122576990, transcript variant X4
uncharacterized LOC122576990, transcript variant X3
uncharacterized protein LOC122576990 isoform X2
uncharacterized protein LOC122576990 isoform X1
integrin alpha-5-like, transcript variant X2
integrin alpha-5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cancer-related nucleoside-triphosphatase homolog, transcript variant X2
cancer-related nucleoside-triphosphatase homolog, transcript variant X1
cancer-related nucleoside-triphosphatase homolog isoform X1
cancer-related nucleoside-triphosphatase homolog, transcript variant X3
cancer-related nucleoside-triphosphatase homolog isoform X2
serine/threonine-protein phosphatase 5, transcript variant X2
serine/threonine-protein phosphatase 5, transcript variant X1
isopentenyl-diphosphate Delta-isomerase 1
arylsulfatase B-like, transcript variant X5
arylsulfatase B-like, transcript variant X3
arylsulfatase B-like, transcript variant X1
arylsulfatase B-like, transcript variant X4
arylsulfatase B-like, transcript variant X2
protein Wnt-11b-2-like, transcript variant X1
protein Wnt-11b-2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein Wnt-11b-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein Wnt-11b-2-like, transcript variant X4
protein Wnt-11b-2-like, transcript variant X5
protein Wnt-11b-2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein Wnt-11b-2-like, transcript variant X7
EF-hand domain-containing family member C2-like, transcript variant X1
EF-hand domain-containing family member C2-like, transcript variant X2
EF-hand domain-containing family member C2-like, transcript variant X3
EF-hand domain-containing family member C2-like isoform X1
EF-hand domain-containing family member C2-like isoform X2
EF-hand domain-containing family member C2-like isoform X3
uncharacterized LOC122577149, transcript variant X2
uncharacterized LOC122577149, transcript variant X5
uncharacterized LOC122577149, transcript variant X8
uncharacterized LOC122577149, transcript variant X4
uncharacterized LOC122577149, transcript variant X6
uncharacterized LOC122577149, transcript variant X3
uncharacterized LOC122577149, transcript variant X1
uncharacterized LOC122577149, transcript variant X7
extended synaptotagmin-2, transcript variant X2
extended synaptotagmin-2, transcript variant X4
extended synaptotagmin-2, transcript variant X1
extended synaptotagmin-2, transcript variant X5
extended synaptotagmin-2, transcript variant X3
serine incorporator 1, transcript variant X3
serine incorporator 1, transcript variant X2
serine incorporator 1, transcript variant X1
serine incorporator 1, transcript variant X5
serine incorporator 1, transcript variant X8
serine incorporator 1, transcript variant X4
serine incorporator 1, transcript variant X6
serine incorporator 1, transcript variant X7
nose resistant to fluoxetine protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
gustatory receptor for sugar taste 64f-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gustatory receptor for sugar taste 64f-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gustatory receptor for sugar taste 64f-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
gustatory receptor for sugar taste 64f-like isoform X1
gustatory receptor for sugar taste 64f-like isoform X3
gustatory receptor for sugar taste 64f-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
gustatory receptor for sugar taste 64f-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
gustatory receptor 5a for trehalose-like isoform X2
gustatory receptor 5a for trehalose-like isoform X1
gustatory receptor for sugar taste 64f-like isoform X4
28S ribosomal protein S14, mitochondrial
elongation factor 1-alpha, transcript variant X1
elongation factor 1-alpha, transcript variant X2
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X2
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X7
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X3
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X1
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X6
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclic nucleotide-gated cation channel alpha-3-like, transcript variant X9
cGMP-gated cation channel alpha-1-like isoform X6
cyclic nucleotide-gated cation channel alpha-3-like isoform X7
cGMP-gated cation channel alpha-1-like isoform X2
cGMP-gated cation channel alpha-1-like isoform X4
cGMP-gated cation channel alpha-1-like isoform X1
cGMP-gated cation channel alpha-1-like isoform X5
cGMP-gated cation channel alpha-1-like isoform X3
cyclic nucleotide-gated cation channel alpha-3-like isoform X8
choline-phosphate cytidylyltransferase A-like, transcript variant X5
choline-phosphate cytidylyltransferase A-like, transcript variant X1
choline-phosphate cytidylyltransferase A-like, transcript variant X6
choline-phosphate cytidylyltransferase A-like, transcript variant X2
choline-phosphate cytidylyltransferase A-like, transcript variant X4
choline-phosphate cytidylyltransferase A-like, transcript variant X3
choline-phosphate cytidylyltransferase A-like, transcript variant X7
choline-phosphate cytidylyltransferase A-like isoform X2
choline-phosphate cytidylyltransferase A-like isoform X1
choline-phosphate cytidylyltransferase A-like isoform X3
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
chromatin modification-related protein EAF1-like, transcript variant X3
chromatin modification-related protein EAF1-like, transcript variant X8
chromatin modification-related protein EAF1-like, transcript variant X6
chromatin modification-related protein EAF1-like, transcript variant X4
chromatin modification-related protein EAF1-like, transcript variant X1
chromatin modification-related protein EAF1-like, transcript variant X2
chromatin modification-related protein EAF1-like, transcript variant X11
chromatin modification-related protein EAF1-like, transcript variant X7
chromatin modification-related protein EAF1-like, transcript variant X9
chromatin modification-related protein EAF1-like, transcript variant X5
chromatin modification-related protein EAF1-like, transcript variant X10
chromatin modification-related protein EAF1-like isoform X1
chromatin modification-related protein EAF1-like isoform X3
chromatin modification-related protein EAF1-like isoform X2
chromatin modification-related protein EAF1-like isoform X5
chromatin modification-related protein EAF1-like isoform X6
chromatin modification-related protein EAF1-like isoform X4
chromatin modification-related protein EAF1-like isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
chromatin modification-related protein EAF1-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromatin modification-related protein EAF1-like, transcript variant X15
chromatin modification-related protein EAF1-like, transcript variant X13
chromatin modification-related protein EAF1-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chromatin modification-related protein EAF1-like, transcript variant X17
chromatin modification-related protein EAF1-like, transcript variant X14
uncharacterized LOC122576903, transcript variant X2
uncharacterized LOC122576903, transcript variant X1
uncharacterized LOC122576902, transcript variant X3
uncharacterized LOC122576902, transcript variant X1
uncharacterized LOC122576902, transcript variant X2
zinc finger protein 567-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger protein 567-like, transcript variant X3
zinc finger protein 567-like, transcript variant X1
gamma-tubulin complex component 4, transcript variant X3
gamma-tubulin complex component 4, transcript variant X2
gamma-tubulin complex component 4, transcript variant X1
vesicle transport protein USE1, transcript variant X5
vesicle transport protein USE1, transcript variant X1
vesicle transport protein USE1, transcript variant X4
vesicle transport protein USE1, transcript variant X2
vesicle transport protein USE1, transcript variant X3
vesicle transport protein USE1 isoform X1
vesicle transport protein USE1 isoform X2
vesicle transport protein USE1 isoform X3
integrator complex subunit 11, transcript variant X3
integrator complex subunit 11, transcript variant X1
integrator complex subunit 11, transcript variant X2
uncharacterized LOC122576960, transcript variant X1
uncharacterized LOC122576960, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
uncharacterized LOC122576959, transcript variant X1
uncharacterized LOC122576959, transcript variant X2
transfer RNA serine (anticodon CGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122576958, transcript variant X2
uncharacterized LOC122576958, transcript variant X3
uncharacterized LOC122576958, transcript variant X1
putative uncharacterized protein DDB_G0286901
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
uncharacterized LOC122576962, transcript variant X2
uncharacterized LOC122576962, transcript variant X7
uncharacterized LOC122576962, transcript variant X3
uncharacterized LOC122576962, transcript variant X8
uncharacterized LOC122576962, transcript variant X4
uncharacterized LOC122576962, transcript variant X9
uncharacterized LOC122576962, transcript variant X10
uncharacterized LOC122576962, transcript variant X5
uncharacterized protein LOC122576962 isoform X2
uncharacterized protein LOC122576962 isoform X4
uncharacterized LOC122576962, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC122576962, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122576962, transcript variant X1
uncharacterized protein LOC122576962 isoform X1
uncharacterized protein LOC122576962 isoform X3
uncharacterized protein LOC122576962 isoform X5
uncharacterized LOC122576962, transcript variant X12
uncharacterized protein LOC122576962 isoform X6
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X3
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X1
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase, transcript variant X4
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X2
probable Dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase isoform X3
transcriptional adapter 2B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transcriptional adapter 2B, transcript variant X1
transcriptional adapter 2B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transcriptional adapter 2B, transcript variant X3
transcriptional adapter 2B, transcript variant X4
transcriptional adapter 2B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transcriptional adapter 2B, transcript variant X8
transcriptional adapter 2B, transcript variant X6
transcriptional adapter 2B, transcript variant X9
uncharacterized LOC122576968, transcript variant X2
uncharacterized LOC122576968, transcript variant X3
uncharacterized LOC122576968, transcript variant X1
ejaculatory bulb-specific protein 3-like
protein sneaky-like, transcript variant X1
protein sneaky-like, transcript variant X2
protein sneaky-like, transcript variant X3
protein sneaky-like, transcript variant X4
uncharacterized LOC122576909, transcript variant X1
uncharacterized LOC122576909, transcript variant X2
uncharacterized protein LOC122576909 isoform X2
uncharacterized protein LOC122576909 isoform X1
uncharacterized LOC122576913, transcript variant X1
uncharacterized LOC122576913, transcript variant X2
uncharacterized LOC122576913, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DNA topoisomerase 2-binding protein 1-A-like, transcript variant X2
DNA topoisomerase 2-binding protein 1-A-like, transcript variant X4
DNA topoisomerase 2-binding protein 1-A-like, transcript variant X1
DNA topoisomerase 2-binding protein 1-A-like, transcript variant X3
DNA topoisomerase 2-binding protein 1-like isoform X2
DNA topoisomerase 2-binding protein 1-A-like isoform X4
DNA topoisomerase 2-binding protein 1-like isoform X1
DNA topoisomerase 2-binding protein 1-like isoform X3
DNA topoisomerase 2-binding protein 1-A-like, transcript variant X5
DNA topoisomerase 2-binding protein 1-A-like isoform X5
UPF0692 protein CG33108, transcript variant X6
UPF0692 protein CG33108, transcript variant X2
UPF0692 protein CG33108, transcript variant X1
UPF0692 protein CG33108, transcript variant X5
UPF0692 protein CG33108, transcript variant X3
UPF0692 protein CG33108, transcript variant X4
phosphofurin acidic cluster sorting protein 2, transcript variant X4
phosphofurin acidic cluster sorting protein 2, transcript variant X3
phosphofurin acidic cluster sorting protein 2, transcript variant X5
phosphofurin acidic cluster sorting protein 2, transcript variant X2
phosphofurin acidic cluster sorting protein 2, transcript variant X1
phosphofurin acidic cluster sorting protein 2, transcript variant X6
phosphofurin acidic cluster sorting protein 2 isoform X4
phosphofurin acidic cluster sorting protein 2 isoform X3
phosphofurin acidic cluster sorting protein 2 isoform X5
phosphofurin acidic cluster sorting protein 2 isoform X2
phosphofurin acidic cluster sorting protein 2 isoform X1
phosphofurin acidic cluster sorting protein 2 isoform X6
uncharacterized LOC122576910, transcript variant X1
uncharacterized LOC122576910, transcript variant X2
uncharacterized LOC122576911, transcript variant X2
uncharacterized LOC122576911, transcript variant X1
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glucose dehydrogenase [FAD, quinone]-like, transcript variant X25
glucose dehydrogenase [FAD, quinone]-like, transcript variant X27
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
glucose dehydrogenase [FAD, quinone]-like, transcript variant X23
glucose dehydrogenase [FAD, quinone]-like, transcript variant X17
glucose dehydrogenase [FAD, quinone]-like, transcript variant X16
glucose dehydrogenase [FAD, quinone]-like, transcript variant X10
glucose dehydrogenase [FAD, quinone]-like, transcript variant X9
glucose dehydrogenase [FAD, quinone]-like, transcript variant X3
glucose dehydrogenase [FAD, quinone]-like, transcript variant X5
glucose dehydrogenase [FAD, quinone]-like, transcript variant X4
glucose dehydrogenase [FAD, quinone]-like, transcript variant X8
glucose dehydrogenase [FAD, quinone]-like, transcript variant X20
glucose dehydrogenase [FAD, quinone]-like, transcript variant X7
glucose dehydrogenase [FAD, quinone]-like, transcript variant X12
glucose dehydrogenase [FAD, quinone]-like, transcript variant X21
glucose dehydrogenase [FAD, quinone]-like, transcript variant X6
glucose dehydrogenase [FAD, quinone]-like, transcript variant X11
glucose dehydrogenase [FAD, quinone]-like, transcript variant X13
glucose dehydrogenase [FAD, quinone]-like, transcript variant X18
glucose dehydrogenase [FAD, quinone]-like, transcript variant X19
glucose dehydrogenase [FAD, quinone]-like, transcript variant X14
glucose dehydrogenase [FAD, quinone]-like, transcript variant X15
glucose dehydrogenase [FAD, quinone]-like, transcript variant X24
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
glucose dehydrogenase [FAD, quinone]-like, transcript variant X22
glucose dehydrogenase [FAD, quinone]-like, transcript variant X26
glucose dehydrogenase [FAD, quinone]-like isoform X1
glucose dehydrogenase [FAD, quinone]-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
glucose dehydrogenase [FAD, quinone]-like
uncharacterized LOC122577059, transcript variant X1
uncharacterized LOC122577059, transcript variant X2
trafficking kinesin-binding protein milt, transcript variant X6
trafficking kinesin-binding protein milt, transcript variant X5
trafficking kinesin-binding protein milt, transcript variant X8
trafficking kinesin-binding protein milt, transcript variant X4
trafficking kinesin-binding protein milt, transcript variant X3
trafficking kinesin-binding protein milt, transcript variant X1
trafficking kinesin-binding protein milt, transcript variant X2
trafficking kinesin-binding protein milt, transcript variant X10
trafficking kinesin-binding protein milt, transcript variant X9
trafficking kinesin-binding protein milt, transcript variant X7
trafficking kinesin-binding protein milt, transcript variant X11
trafficking kinesin-binding protein milt isoform X4
trafficking kinesin-binding protein milt isoform X3
trafficking kinesin-binding protein milt isoform X6
trafficking kinesin-binding protein milt isoform X2
trafficking kinesin-binding protein milt isoform X1
trafficking kinesin-binding protein milt isoform X5
uncharacterized LOC122577063, transcript variant X5
uncharacterized LOC122577063, transcript variant X3
uncharacterized LOC122577063, transcript variant X6
uncharacterized LOC122577063, transcript variant X4
uncharacterized LOC122577063, transcript variant X1
uncharacterized LOC122577063, transcript variant X2
uncharacterized LOC122577062, transcript variant X1
uncharacterized LOC122577062, transcript variant X3
uncharacterized LOC122577062, transcript variant X2
uncharacterized LOC122577060, transcript variant X2
uncharacterized LOC122577060, transcript variant X1
zinc finger and BTB domain-containing protein 12-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 12-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 12-like, transcript variant X1
zinc finger and BTB domain-containing protein 12-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger and BTB domain-containing protein 12-like, transcript variant X4
zinc finger and BTB domain-containing protein 12-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 12-like, transcript variant X6
zinc finger and BTB domain-containing protein 12-like, transcript variant X11
zinc finger and BTB domain-containing protein 12-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger and BTB domain-containing protein 12-like, transcript variant X7
zinc finger and BTB domain-containing protein 12-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122577053 isoform X1
uncharacterized protein LOC122577053 isoform X4
uncharacterized protein LOC122577053 isoform X2
uncharacterized protein LOC122577053 isoform X5
uncharacterized protein LOC122577053 isoform X3
zinc finger and BTB domain-containing protein 12-like isoform X6
uncharacterized LOC122577055, transcript variant X4
uncharacterized LOC122577055, transcript variant X5
uncharacterized LOC122577055, transcript variant X7
uncharacterized LOC122577055, transcript variant X2
uncharacterized LOC122577055, transcript variant X3
uncharacterized LOC122577055, transcript variant X6
uncharacterized LOC122577055, transcript variant X1
uncharacterized LOC122577061, transcript variant X5
uncharacterized LOC122577061, transcript variant X4
uncharacterized LOC122577061, transcript variant X3
uncharacterized LOC122577061, transcript variant X6
uncharacterized LOC122577061, transcript variant X7
uncharacterized LOC122577061, transcript variant X1
uncharacterized LOC122577061, transcript variant X2
elongation of very long chain fatty acids protein 6-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122577048, transcript variant X7
uncharacterized LOC122577046, transcript variant X3
uncharacterized LOC122577050, transcript variant X2
uncharacterized LOC122577050, transcript variant X1
uncharacterized LOC122577048, transcript variant X2
uncharacterized LOC122577048, transcript variant X8
uncharacterized LOC122577048, transcript variant X5
uncharacterized LOC122577048, transcript variant X4
uncharacterized LOC122577048, transcript variant X6
uncharacterized LOC122577048, transcript variant X3
uncharacterized LOC122577048, transcript variant X1
uncharacterized LOC122577046, transcript variant X2
uncharacterized LOC122577046, transcript variant X1
uncharacterized LOC122577049, transcript variant X1
uncharacterized LOC122577049, transcript variant X2
uncharacterized LOC122577049, transcript variant X3
uncharacterized LOC122576843, transcript variant X4
uncharacterized LOC122576843, transcript variant X5
uncharacterized LOC122576843, transcript variant X2
uncharacterized LOC122576843, transcript variant X1
uncharacterized LOC122576843, transcript variant X3
uncharacterized protein LOC122576843 isoform X4
uncharacterized protein LOC122576843 isoform X3
uncharacterized protein LOC122576843 isoform X1
uncharacterized protein LOC122576843 isoform X2
lysophospholipid acyltransferase 5, transcript variant X2
lysophospholipid acyltransferase 5, transcript variant X11
lysophospholipid acyltransferase 5, transcript variant X10
lysophospholipid acyltransferase 5, transcript variant X8
lysophospholipid acyltransferase 5, transcript variant X9
lysophospholipid acyltransferase 5, transcript variant X7
lysophospholipid acyltransferase 5, transcript variant X6
lysophospholipid acyltransferase 5, transcript variant X1
lysophospholipid acyltransferase 5, transcript variant X5
lysophospholipid acyltransferase 5, transcript variant X4
lysophospholipid acyltransferase 5, transcript variant X3
lysophospholipid acyltransferase 5 isoform X2
lysophospholipid acyltransferase 5 isoform X1
lysophospholipid acyltransferase 5 isoform X3
leucine-rich repeat extensin-like protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine-rich repeat extensin-like protein 2
leucine-rich repeat extensin-like protein 2, transcript variant X2
uncharacterized LOC122576823, transcript variant X1
uncharacterized LOC122576823, transcript variant X2
uncharacterized LOC122576824, transcript variant X2
uncharacterized LOC122576824, transcript variant X1
uncharacterized LOC122576891, transcript variant X2
uncharacterized LOC122576891, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122576874, transcript variant X4
uncharacterized LOC122576874, transcript variant X1
uncharacterized LOC122576874, transcript variant X5
uncharacterized LOC122576874, transcript variant X2
uncharacterized LOC122576874, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
PHD finger-like domain-containing protein 5A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
PHD finger-like domain-containing protein 5A, transcript variant X3
PHD finger-like domain-containing protein 5A isoform X2
PHD finger-like domain-containing protein 5A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
PHD finger-like domain-containing protein 5A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC122576888, transcript variant X2
uncharacterized LOC122576888, transcript variant X1
uncharacterized LOC122576880, transcript variant X7
uncharacterized LOC122576880, transcript variant X6
uncharacterized LOC122576880, transcript variant X2
uncharacterized LOC122576880, transcript variant X1
uncharacterized LOC122576880, transcript variant X3
uncharacterized LOC122576880, transcript variant X5
uncharacterized LOC122576880, transcript variant X4
uncharacterized protein LOC122576880 isoform X1
uncharacterized protein LOC122576880 isoform X2
uncharacterized protein LOC122576880 isoform X3
telomerase reverse transcriptase-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
telomerase reverse transcriptase-like, transcript variant X1
telomerase reverse transcriptase-like, transcript variant X2
telomerase reverse transcriptase-like, transcript variant X3
guanine nucleotide-binding protein subunit beta-like protein 1, transcript variant X1
guanine nucleotide-binding protein subunit beta-like protein 1, transcript variant X2
guanine nucleotide-binding protein subunit beta-like protein 1, transcript variant X3
guanine nucleotide-binding protein subunit beta-like protein 1 isoform X1
guanine nucleotide-binding protein subunit beta-like protein 1 isoform X2
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X2
26S proteasome non-ATPase regulatory subunit 10-like, transcript variant X1
26S proteasome non-ATPase regulatory subunit 10-like isoform X1
26S proteasome non-ATPase regulatory subunit 10-like isoform X2
myosin heavy chain, non-muscle, transcript variant X2
myosin heavy chain, non-muscle isoform X2
myosin heavy chain, non-muscle, transcript variant X5
myosin heavy chain, non-muscle, transcript variant X4
myosin heavy chain, non-muscle, transcript variant X3
myosin heavy chain, non-muscle, transcript variant X1
myosin heavy chain, non-muscle isoform X3
myosin heavy chain, non-muscle isoform X4
myosin heavy chain, non-muscle isoform X1
probable low-specificity L-threonine aldolase 1, transcript variant X2
probable low-specificity L-threonine aldolase 1, transcript variant X5
probable low-specificity L-threonine aldolase 1, transcript variant X1
probable low-specificity L-threonine aldolase 1, transcript variant X6
probable low-specificity L-threonine aldolase 1, transcript variant X8
probable low-specificity L-threonine aldolase 1, transcript variant X9
probable low-specificity L-threonine aldolase 1, transcript variant X11
probable low-specificity L-threonine aldolase 1, transcript variant X10
probable low-specificity L-threonine aldolase 1, transcript variant X4
probable low-specificity L-threonine aldolase 1, transcript variant X3
probable low-specificity L-threonine aldolase 1 isoform X3
probable low-specificity L-threonine aldolase 1 isoform X5
uncharacterized protein LOC122576879 isoform X1
probable low-specificity L-threonine aldolase 1 isoform X8
probable low-specificity L-threonine aldolase 1 isoform X6
probable low-specificity L-threonine aldolase 1 isoform X7
probable low-specificity L-threonine aldolase 1, transcript variant X7
uncharacterized protein LOC122576879 isoform X4
uncharacterized LOC122576889, transcript variant X2
uncharacterized LOC122576889, transcript variant X1
phospholipase B1, membrane-associated-like, transcript variant X2
phospholipase B1, membrane-associated-like, transcript variant X1
phospholipase B1, membrane-associated-like isoform X1
phospholipase B1, membrane-associated-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative fatty acyl-CoA reductase CG5065
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 8% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
phospholipase B1, membrane-associated-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
putative fatty acyl-CoA reductase CG8306
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 55% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
putative fatty acyl-CoA reductase CG5065, transcript variant X1
putative fatty acyl-CoA reductase CG5065, transcript variant X2
fatty acyl-CoA reductase 1-like, transcript variant X1
fatty acyl-CoA reductase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 68% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
putative fatty acyl-CoA reductase CG5065, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
putative fatty acyl-CoA reductase CG5065 isoform X1
putative fatty acyl-CoA reductase CG5065 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC122576932, transcript variant X1
uncharacterized LOC122576932, transcript variant X2
uncharacterized protein LOC122576932 isoform X2
uncharacterized protein LOC122576932 isoform X1
uncharacterized LOC122576930, transcript variant X2
uncharacterized LOC122576930, transcript variant X1
uncharacterized LOC122577155, transcript variant X4
uncharacterized LOC122577155, transcript variant X1
uncharacterized LOC122577155, transcript variant X2
uncharacterized LOC122577155, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 73% coverage of the annotated genomic feature by RNAseq alignments
dynein axonemal heavy chain 9-like, transcript variant X1
dynein axonemal heavy chain 9-like, transcript variant X2
golgin subfamily A member 6-like protein 22
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 57% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: golgin subfamily A member 6-like protein 22
golgin subfamily A member 6-like protein 6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: golgin subfamily A member 6-like protein 6
SET domain-containing protein SmydA-8-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SET domain-containing protein SmydA-8-like, transcript variant X6
SET domain-containing protein SmydA-8-like, transcript variant X11
SET domain-containing protein SmydA-8-like, transcript variant X14
SET domain-containing protein SmydA-8-like, transcript variant X12
SET domain-containing protein SmydA-8-like, transcript variant X10
SET domain-containing protein SmydA-8-like, transcript variant X9
SET domain-containing protein SmydA-8-like, transcript variant X2
SET domain-containing protein SmydA-8-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SET domain-containing protein SmydA-8-like, transcript variant X1
SET domain-containing protein SmydA-8-like, transcript variant X15
SET domain-containing protein SmydA-8-like, transcript variant X4
SET domain-containing protein SmydA-8-like isoform X6
SET domain-containing protein SmydA-8-like isoform X1
SET domain-containing protein SmydA-8-like isoform X2
SET domain-containing protein SmydA-8-like isoform X4
SET domain-containing protein SmydA-8-like isoform X7
SET domain-containing protein SmydA-8-like, transcript variant X7
SET domain-containing protein SmydA-8-like isoform X3
SET domain-containing protein SmydA-8-like, transcript variant X8
SET domain-containing protein SmydA-8-like, transcript variant X13
SET domain-containing protein SmydA-8-like isoform X5
uncharacterized LOC122577006, transcript variant X1
uncharacterized LOC122577006, transcript variant X4
uncharacterized LOC122577006, transcript variant X3
uncharacterized LOC122577006, transcript variant X2
uncharacterized LOC122577002, transcript variant X3
uncharacterized LOC122577002, transcript variant X2
uncharacterized LOC122577002, transcript variant X1
uncharacterized protein LOC122577002 isoform X3
uncharacterized protein LOC122577002 isoform X2
uncharacterized protein LOC122577002 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
ATP-dependent RNA helicase DDX51-like, transcript variant X2
ATP-dependent RNA helicase DDX51-like, transcript variant X1
probable ATP-dependent RNA helicase Dbp73D
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
4-coumarate--CoA ligase 1-like, transcript variant X2
4-coumarate--CoA ligase 1-like, transcript variant X1
4-coumarate--CoA ligase 1-like isoform X1
4-coumarate--CoA ligase 1-like, transcript variant X3
4-coumarate--CoA ligase 1-like isoform X2
calcium and integrin-binding family member 3-like, transcript variant X1
calcium and integrin-binding family member 3-like, transcript variant X2
calcium and integrin-binding family member 3-like isoform X1
calcium and integrin-binding protein 1-like isoform X2
protein FAM166C-like, transcript variant X1
protein FAM166C-like, transcript variant X2
LOW QUALITY PROTEIN: inner centromere protein-like
uncharacterized LOC122577144, transcript variant X1
uncharacterized LOC122577144, transcript variant X2
uncharacterized protein LOC122577144 isoform X1
uncharacterized LOC122577144, transcript variant X4
uncharacterized LOC122577144, transcript variant X5
uncharacterized LOC122577144, transcript variant X3
uncharacterized protein LOC122577144 isoform X2